American Express Declares Dividends on Series B and C Preferred Stock
American Express Company (NYSE: AXP) has declared the following dividends on the Company’s Series B and C Preferred Shares:
- A quarterly dividend on the Company’s 5.200% Fixed Rate / Floating Rate Noncumulative Preferred Shares, Series B, of $9,059.25 per share (which is equivalent to $9.05925 per related Depositary Share). The dividend is payable on August 16, 2021, to shareholders of record on August 1, 2021.
- A quarterly dividend on the Company’s 4.900% Fixed Rate / Floating Rate Noncumulative Preferred Shares, Series C, of $8,698.80 per share (which is equivalent to $8.69880 per related Depositary Share). The dividend is payable on September 15, 2021, to shareholders of record on September 1, 2021.
ABOUT AMERICAN EXPRESS
American Express is a globally integrated payments company, providing customers with access to products, insights and experiences that enrich lives and build business success. Learn more at americanexpress.com and connect with us on facebook.com/americanexpress , instagram.com/americanexpress , linkedin.com/company/american-express , twitter.com/americanexpress , and youtube.com/americanexpress .
Key links to products, services and corporate responsibility information: charge and credit cards , business credit cards , travel services , gift cards , prepaid cards , merchant services , Accertify , InAuth , corporate card , business travel , and corporate responsibility .
Source: American Express Company
About Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
MOODY’S-ESG3.8.2021 10:16:06 CEST | Press release
Moody’s ESG Solutions Launches Solution to Help Investors Assess Alignment With UN Global Compact
BOEHRINGER-INGELHEIM3.8.2021 10:02:05 CEST | Press release
First half of 2021: Boehringer Ingelheim makes fundamental progress in research and development
SES-NETWORKS/ORANGE3.8.2021 08:52:03 CEST | Press release
SES Networks Expands Partnership With Orange to Enhance Maritime Services
GOPHER-INVESTMENTS3.8.2021 08:02:12 CEST | Press release
Gopher Response to Statement by Playtech, Related Clarifications and Reasons Why Shareholders Should VOTE AGAINST the Consortium Offer
RELIEF3.8.2021 07:05:13 CEST | Press release
Relief Announces Receipt of U.S. FDA Orphan Drug Designation for the use of RLF-100 (aviptadil) in the Treatment of Sarcoidosis
P.I.-WORKS3.8.2021 07:02:06 CEST | Press release
Smart Engages P.I. Works for Expanded Network Automation Solution
CA-PERSONALIS2.8.2021 22:07:05 CEST | Press release
Personalis, Inc. Publishes New Data Demonstrating a Novel Composite Biomarker NEOPS™ for Predicting Response to Cancer Immunotherapy in Late-Stage Melanoma Patients
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.Visit our pressroom